The QualityStocks Daily Thursday, May 17th, 2018

Today's Top 3 Investment Newsletters

MarketClub Analysis (CARV) +197.30%

MarketBeat (AAX) +138.10%

MissionIR (PVOTF) +37.44%

The QualityStocks Daily Stock List

Workhorse Group, Inc. (WKHS)

Stocktwits, MarketWatch, Morningstar, The Street, CapitalCube, GuruFocus, Simply Wall St, InvestorsHub, 4-Traders, Stockhouse, Equity Clock, Investing, Zacks, Investopedia, Last10K, Business Insider, and StreetInsider reported on Workhorse Group, Inc. (WKHS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Workhorse Group, Inc. is a technology company centered on providing sustainable and cost-effective electric mobility solutions to the commercial electric transportation sector. An American original equipment manufacturer (OEM), the Company designs and builds high performance battery-electric vehicles including trucks and aircraft. Workhorse Group is headquartered in Loveland, Ohio. The Company’s shares trade on the NasdaqCM.

Moreover, Workhorse Group develops cloud-based, real-time telematics performance monitoring systems. These systems are completely integrated with the Company’s vehicles. They enable fleet operators to optimize energy and route efficiency.

The design of all Workhorse vehicles is to make the movement of people and goods more efficient and less harmful to the environment. Workhorse Group is a foremost manufacturer of medium-duty electric step vans in the United States targeting commercial fleets. The Company is the only OEM building electrified medium-duty vehicles in the U.S.

Workhorse Group is developing the Workhorse W-15, the U.S.’ first light-duty pickup truck with electric powertrain aimed at commercial fleets. Target customers include delivery fleets, utility companies, telecommunications companies, municipalities and more.

The Company designs and produces battery-electric power trains in its 50,000 sq. ft. facility in Loveland for its new Workhorse chassis. Its approach to building its battery electric power trains uses proven, automotive-grade, mass-produced parts together with its custom designed, proprietary control software.

Workhorse Group has its N-GEN Electric Delivery Van; the W-15 electric pickup truck with extended range; the E-Gen Step Van; the SureFly™ Helicopter; the HorseFly™ Autonomous Drone Delivery System; and the METRON™ Telematics and Asset Tracking Software.

At the beginning of May, Dana Incorporated (DAN) and Workhorse Group announced the design, development, and production of a city delivery vehicle featuring Dana's Spicer® Electrified™ integrated e-Drive axle. Expanding the established Spicer Electrified portfolio, the new integrated e-Drive axle is ideal for the Workhorse vehicle.

It delivers considerable efficiency for its city delivery duty cycle. It does so while offering a major weight savings of 388 pounds, permitting higher payload and battery capacity. Dana is an international leader in highly engineered solutions for improving the efficiency, performance, as well as sustainability of powered vehicles and machinery.

For Q1 2018, Workhorse Group announced an expanded partnership with UPS for up to 1000 N-GEN electric delivery vans. In addition, the Company deployed the first N-GEN production intent vehicle executing live deliveries in the San Francisco Bay Area. Moreover, it received a patent for the HorseFly™ truck-launched drone delivery system from the United States Patent and Trademark Office (USPTO).

Furthermore, Workhorse Group initiated a change-over to a production facility in preparation for assembly of N-GEN and W-15 platforms, boosting line capacity to 30 units per day.

Yesterday, Workhorse Group announced that the HorseFly truck-launched Autonomous Drone Package Delivery System is now making real-life package deliveries to homes in the Cincinnati area in a pilot program with the City of Loveland and the FAA (Federal Aviation Administration). Consumers in select Cincinnati zip codes chose to accept packages from Horsefly through the Workhorse Ares Drone Package Delivery App.

The design of this APP is to seamlessly integrate with existing online e-commerce platforms. The HorseFly UAV Delivery System is a custom-built, high efficiency delivery UAV. It is completely integrated with the Workhorse line of electric delivery trucks.

Mr. Steve Burns, Chief Executive Officer of Workhorse Group, said, "We feel this is a game-changing moment to innovate the way packages are delivered for many years to come. By not only reducing the expense of last mile delivery, but also providing the consumer with the ability to opt-in, visualize, and confirm their package delivery on their property, we have re-imagined home delivery."

Workhorse Group, Inc. (WKHS), closed Thursday's trading session at $2.75, up 1.48%, on 167,293 volume with 417 trades. The average volume for the last 60 days is 198,615 and the stock's 52-week low/high is $2.21/$4.89.


Mikros Systems Corp. (MKRS)

OTCEquity, PennyStocks24, AwesomeStocks, Wall Street Mover, PricelessPennyStocks, Promotion Stock Secrets,, Fast Money Alerts, Actual Gains, AddictivePennyStocks, Chatter Box Stocks, StockLockandLoad,, StockRockandRoll,, ResearchOTC, and OTPicks reported on Mikros Systems Corp. (MKRS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mikros Systems Corp. is a provider of advanced maintenance and monitoring solutions for mission-critical systems. The Company is an advanced technology enterprise that designs and manufactures specialized electronic systems for the Department of Defense. Its chief business is to pursue and obtain contracts from the Department of Homeland Security, the U.S. Navy, and other governmental authorities. The Company is headquartered in Princeton, New Jersey, and has its Manufacturing and Depot Center in Largo, Florida.

Mikros produces advanced maintenance systems for the Navy. These include the ADEPT Maintenance Automation Workstation and the ADSSS Condition Based Maintenance system for the Littoral Combat Ship. ADEPT systems are in use daily for performance optimization of advanced radar systems.

The Company has developed, delivered, and installed military-grade equipment to Federal customers’ for more than 30 years. Its capabilities include technology management, electronic systems engineering and integration, radar systems engineering, command, control, communications, computers and intelligence systems engineering, and communications engineering.

Mikros Systems’ Lifecycle Support capability is focused on ensuring the systematic interactions between Integrated Logistics Support (ILS), Depot, and Field Support activities are integrated to accomplish the highest levels of system readiness. The Company purchased certain software products, intellectual property (IP) and related assets from VSE Corp. The main software programs purchased by Mikros are the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs.

The Diagnostic Profiler software is used globally by many multinational companies for optimized maintenance of varied product lines. Diagnostic Profiler is also used by the U.S. Air Force for depot test programs.

Prognostics Framework is used by the U.S. Army for many missile defense systems. These software products provide Mikros Systems with the opportunity to service commercial customers and additional Department of Defense customers outside the Navy.

In September 2017, Mikros Systems announced that it received the second production order awarded under its recent multi-year $35M contract with the Naval Surface Warfare Center in Crane, IN. This order covers new production deliveries of Mikros' Adaptive Diagnostic Electronic Portable Testset (ADEPT). It is valued at $2.4 million. The ADEPT units will be produced at the Mikros Manufacturing and Depot Center in Largo, FL.

Mikros has successfully completed the first ship and shore installation and testing of its ADEPT Distance Support Sensor Suite (ADSSS) on the Littoral Combat Ship USS INDEPENDENCE (LCS 2). As installed on LCS 2, ADSSS will utilize the Company’s proprietary model-based Prognostics Framework technology to monitor combat system elements to detect and predict on-ship system failures and apply predictive analytics to on-shore systems to detect broader maintenance trends and patterns across the fleet.

ADSSS Program Manager, Lori Ogles, said earlier in December, "Mikros has been a proud partner of the U.S. Navy for over fifteen years. We are honored to continue to support the readiness of U.S. Navy combat systems with our condition-based maintenance solution and we look forward to expanding the ADSSS technology to additional LCS and U.S. Naval platforms."

Mikros Systems Corp. (MKRS), closed Thursday's trading session at $0.402, up 3.08%, on 83,727 volume with 19 trades. The average volume for the last 60 days is 19,585 and the stock's 52-week low/high is $0.30/$0.63.


Creative Medical Technology Holdings, Inc. (CELZ)

OTC Markets, InvestorsHub, Stockhouse and MarketWatch reported on Creative Medical Technology Holdings, Inc. (CELZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Creative Medical Technology Holdings, Inc. (CMT) is a clinical stage stem cell company headquartered in Phoenix, Arizona. The Company’s emphasis is on Urology and Neurology employing stem cell treatments. CMT and its affiliate company, Creative Medical Health, Inc., have concentrated on regenerative medical solutions for unmet Urological and Neurological needs since 2011. The Company has a patent portfolio that covers all treatments. CMT lists on the OTC Markets.

CMT (via its own research and collaborations with foremost academic institutions) has acquired a pioneering stem cell (Amniostem), and developed proprietary protocols. Furthermore, it has built a wide-ranging intellectual property (IP) portfolio, developed complete treatment offerings for erectile dysfunction (ED), and launched a 40-patient trial for ED at UCLA. Additionally, CMT is making advances for treating stroke using its newly acquired amniotic fluid-based stem cell.

Amniostem is Amniotic fluid derived stem cell. The Amniostem patent covers means to isolate, grow, and use amniotic fluid derived stem cells in a scalable and commercializable way. Amniostem therapy is a practical protocol for producing therapeutic quality stem cells starting from a small (1-5 ml) amniocentesis sample. Amniostem cells do not require matching with the recipient, as one size fits all.

CMT has its StemSpine™ initiative. This is a treatment designed to reverse the affects of atherosclerosis (the underlying disease that causes disc degeneration). The Company’s solutions include Caverstem™ for Erectile Dysfunction (ED).

CMT announced in February 2018 the creation of CerebroStem LLC. This is a majority owned subsidiary focused on developing stem cell therapies for brain injuries and neurodegenerative diseases. The Company's initial concentration will be treating radiation induced brain damage. This is a major cause of cognitive dysfunction in patients with brain cancer who have received radiation therapy.

Dr. Thomas Ichim will lead CerebroStem. He is currently the Chief Scientific Officer (CSO) of CMT.  Dr. Ichim will serve as President and CSO.  Dr. Ichim has been responsible for three Food and Drug Administration (FDA) cleared Investigational New Drug (IND) Applications in the area of cellular therapy. In addition, Dr. Ichim is the inventor of more than 100 patents and patent applications.

Recently, CMT announced new data demonstrating superior immune modulatory ability of its AmnioStem™ stem cell product when compared head-to-head with bone marrow, adipose tissue, as well as placental tissue mesenchymal stem cells. The data, generated by CMT at its BioLabs research facility in San Diego, California, showed that AmnioStem™ cells were superior at suppressing production of inflammatory mediators, including TNF-alpha, interferon gamma, and interleukin-12 versus other stem cells.

The AmnioStem™ stem cell is covered by an issued US Patent, which was exclusively licensed from the University of California by CMT in 2016. Last week, the Company announced filing of patent application number 62663912 covering the use of its AmnioStem™ stem cells as a means of reducing/reversing natural aging.

Creative Medical Technology Holdings, Inc. (CELZ), closed Thursday's trading session at $0.0216, up 20.00%, on 25,349,707 volume with 542 trades. The average volume for the last 60 days is 50,712,420 and the stock's 52-week low/high is $0.0021/$0.55.


Sun BioPharma, Inc. (SNBP)

AheadoftheBulls, Today's Financial News, HotPennyStocksNow, OTC Picks, Hot Shot Stocks, Wall Street Resources, Beacon Equity Research, AllPennyStocks,, The Dean, FeedBlitz, MicrocapVoice, Greenbackers, CoolPennyStocks, Otcstockexchange, HotOTC, and reported earlier on Sun BioPharma, Inc. (SNBP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sun BioPharma, Inc. is a Biopharmaceutical Company, with its corporate headquarters in Waconia, Minnesota. The Company is developing disruptive therapeutics for the treatment of patients with pancreatic diseases. A clinical-stage biopharmaceutical company, Sun BioPharma’s development programs target diseases of the pancreas. This includes pancreatic cancer and pancreatitis. Sun BioPharma lists on the OTC Markets Group’s OTCQB.

The Company has scientific collaborations with pancreatic disease experts at Cedars Sinai Medical Center in Los Angeles, California; the University of Miami; the University of Florida; the Mayo Clinic Scottsdale; the Austin Health Cancer Trials Centre and the Box Hill Hospital in Melbourne, Australia, and the Ashford Cancer Centre in Adelaide, Australia.

Sun BioPharma’s initial product candidate is SBP-101. This product is for the treatment of patients with pancreatic cancer. Mr. Ray Bergeron, Ph.D. Distinguished Professor Emeritus, University of Florida invented SBP-101. Sun BioPharma’s plan is to develop SBP-101 for the treatment of patients with pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer.

SBP-101 is a first-in-class, proprietary, polyamine compound. The design of it is to exert therapeutic effects in a mechanism specific to the pancreas. The Company originally licensed SBP-101 from the University of Florida in 2011.

Furthermore, Sun BioPharma’s SBP-102 is now in non-clinical feasibility evaluation for the treatment of patients with pancreatitis. In addition, the Company’s SBP-103 is presently in non-clinical exploratory evaluation.

Sun BioPharma earlier announced the completion of the first-in-human safety study of SBP-101 in previously treated patients with pancreatic ductal adenocarcinoma (PDA). SBP-101 was well tolerated. Additionally, signals of efficacy were observed at dose levels below the Maximum Tolerated Dose (MTD).

This past February, Sun BioPharma announced the acceptance by the U.S. Patent and Trademark Office (USPTO) of a provisional application (No. 62/623,641) for its novel manufacturing process developed for its lead drug candidate, SBP-101, now undergoing study for the treatment of patients suffering from pancreatic ductal adenocarcinoma (PDA).

Sun BioPharma’s newest trial, a combination of SBP-101 to be administered with gemcitabine and nab-paclitaxel in previously untreated patients with metastatic pancreatic ductal adenocarcinoma (PDA), is expected to commence dosing patients by the end of this month. Site initiation visits have been completed at two of four participating cancer centers - the Adelaide Cancer Centre in Adelaide, Australia, and the University of Florida in Gainesville, Florida. Both centers are actively recruiting subjects for the study. Two additional sites, both in Australia, will be initiated next month.

Sun BioPharma, Inc. (SNBP), closed Thursday's trading session at $7.50, up 7.14%, on 1,954 volume with 10 trades. The average volume for the last 60 days is 172 and the stock's 52-week low/high is $1.00/$20.90.


Regen BioPharma, Inc. (RGBP)

ProTrader, SmallCapVoice, InvestorTrendz, TopPennyStockMovers, Wall Street Mover, and TheMicrocapNews reported earlier on Regen BioPharma, Inc. (RGBP), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Regen BioPharma, Inc. is a biotechnology company listed on the OTCQB. It works to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company’s goal is to quickly advance these technologies through pre-clinical and Phase I/II clinical trials. Regen BioPharma is currently focusing on checkpoint inhibitor and gene silencing therapies for treating cancer. Checkpoint Immunology, Inc. is a wholly-owned subsidiary of the Company. Regen BioPharma has its corporate office in La Mesa, California.

In addition, Regen BioPharma is concentrating on developing stem cell treatments for aplastic anemia. At present, the Company is developing products treating blood disorders utilizing small molecules and gene silencing (DiffronC), and treating cancer with immunotherapy (dCellVax). Fundamentally, Regen BioPharma is working to increase the quality of life through therapies involving small molecules, stem cell treatments, and the body's own immune system.

Regen is also modulating vital molecular processes in cancer stem cells via its patented molecular targeting approaches (BORIS). Additionally, it is repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).

The Company is focusing on small molecules to activate and inhibit its principal target of interest, NR2F6. It announced in December of 2016 the filing of a [provisional/nonprovisional] utility patent application with the United States Patents and Trademark Office (USPTO) covering NR2F6-silenced CAR T cells.

Beforehand work demonstrated that methodologies developed by the Company and covered under its issued patent #9,091,696 are useful in stimulation of T cell activity. Regen is continuing to develop the NR2F6 program in-house before entering into any potential partnerships.

Regen BioPharma has granted CheckPoint Immunology an exclusive worldwide license to develop and commercialize Regen's NR2F6 technology for human therapeutic use. The aim of the license grant is the separation of Regen BioPharma’s small molecule technology from its other Intellectual Property (IP) to facilitate any future transactions involving small molecule therapies focused on the NR2F6 checkpoint.

This past December, Regen BioPharma announced filing a patent application covering composition of matter and methods of use related to molecules identified in its small molecule program that activate and inhibit NR2F6 (Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans).

Mr. Harry Lander, Ph.D., President and Chief Scientific Officer of Regen BioPharma, said, "The patent application lists several dozen molecules that have a modulatory effect on NR2F6 seen across multiple assays, In particular, we have included the unique structural element that we have identified as required for activation of NR2F6. Of course, we expect to continue to generate more unique small molecules, and we will file additional patent applications at the appropriate time."

Regen BioPharma, Inc. (RGBP), closed Thursday's trading session at $0.027, up 6.22%, on 37,400 volume with 6 trades. The average volume for the last 60 days is 187,524 and the stock's 52-week low/high is $0.018/$0.1277.


Astea International, Inc. (ATEA)

Stocktwits, Zacks, OTC Markets, MarketWatch, InvestorsHub, Stockhouse, Business Insider, and The Street reported on Astea International, Inc. (ATEA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Astea International, Inc. is a global leader in field service and mobile workforce management. The Company’s solutions unify processes, people, parts, and information to focus the entire organization on the creation of sustainable value in highly competitive, international markets. Astea provides integrated solutions to assist in maximizing efficiencies, improve revenues, and enhance customer satisfaction. Astea International is based in Horsham, Pennsylvania.

The Company is a worldwide provider of end-to-end service management software solutions. These solutions offer all the foundations of service lifecycle management. These include customer management, depot repair, service management, asset management, warranty management, forward and reverse logistics, and mobile and optimization.

Astea provides on-premise and cloud delivery models. This allows every company to select the right one that aligns with their strategy and Information Technology (IT) ecosystem.

Astea International has expertise in service management, distribution, logistics, and system applications. These can help an organization streamline business processes, incorporate services best practices, reduce costs, and realize the highest returns from their technology investment. The main elements of the Company’s professional services are impact assessment, consulting services, and training & support.

Astea International, via its Japanese subsidiary, has partnered with Kobelco Systems Corporation. This is to enable wide-ranging Internet of Things (IoT) and Artificial Intelligence (AI) capabilities on its field service management platform, Astea Alliance™.

Kobelco Systems' IoT infrastructure platform and AI analytical service are now completely integrated into the Astea Alliance platform to optimize the maintenance activities of original equipment manufacturers (OEMs), improving overall productivity for assembly lines, plants, and supply chains.

Last month, Astea International and XOi Technologies announced a partnership to expand their combined offerings to field service providers worldwide by integrating XOi's Vision™ into the Astea Alliance™ field service management and mobility platform. Vision™ is an augmented reality and visual intelligence solution.

The two platforms will integrate for customers, validating quality and consistency of field service work, streamlining information sharing and training, and boosting mobile workforce efficiency via technology built for technicians to capture and take advantage of visual intelligence in the field.

Astea International will host a conference call to be broadcast live over the Internet on Tuesday, May 22, 2018. This conference call is to discuss the Company's Q1 2018 financial results. Company Executives will host the call. 

Astea International, Inc. (ATEA), closed Thursday's trading session at $3.80, even for the day. The average volume for the last 60 days is 4,228 and the stock's 52-week low/high is $1.80/$4.1499.


hopTo, Inc. (HPTO)

Tiny Gems, Money Morning, Marketbeat, Wall Street Mover, SmallCapVoice, TopPennyStockMovers, and PennyStocks24 reported earlier on hopTo, Inc. (HPTO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

hopTo, Inc. is a developer of application publishing software and a mobile productivity workspace platform. The hopTo mobile solution delivers a first-rate user experience without compromising enterprise security. It delivers a mobile experience that changes the way one works and lives without any compromises or boundaries. The Company is a Citrix Ready® Premier Partner. hopTo is headquartered in Concord, New Hampshire.

The hopTo mobile solution enables one to completely embrace a mobile lifestyle. hopTo brings a new standard of mobile productivity with custom, touch enabled access to existing Windows applications and documents. hopTo are developers of application software. This includes application virtualization software and cloud computing software for multiple computer operating systems. This includes Windows, UNIX, and a number of Linux-based variants.

hopTo Work enables customers to rapidly transform their legacy applications to become touch friendly on modern mobile devices. Moreover, hopTo worked during 2015 and 2016 to integrate hopTo Work with certain software products offered by Citrix Systems.

The Company’s application publishing software solutions sell under the brand name GO-Global. GO-Global is an application access solution for use and/or resale by independent software vendors (ISVs), corporate enterprises, governmental and educational institutions, and others who desire to leverage cross-platform remote access and Web-enabled access to their existing software applications, as well as those who are installing secure, private cloud environments.

This past November, hopTo announced its financial results for Q3 ended September 30, 2017. For Q3 2017, Revenue was $1.026 million; Net Profit was $254,000; and Basic and Diluted Earnings per Share was $0.03.

Total Revenue for the first nine months of Fiscal Year 2017 was $2.93 million. This represents an increase of about 2.4 percent from $2.86 million for the same period in 2016. This revenue is entirely from hopTo’s GO-Global products and services.

For the first nine months of 2017, hopTo reported a Net Profit of $87,000 or $0.01 per basic and diluted share. This is in comparison with a Net Loss of $1.87 million or $0.19 per basic and diluted share from the same period last year.

Jean-Louis Casabonne, hopTo’s interim Chief Executive Officer, said, "The GO-Global business continues to generate positive cash flow and remains a critical aspect of the company. The GO-Global business has now shown modest growth year over year for both the three and nine month periods ended September 30, 2017 strengthening our belief that it will operate profitably in the future. Early in the third quarter, we completed a sale of seven of our fifty-three granted patents which has further improved the cash position of the Company. This sale included a license back to hopTo for those patents."

hopTo, Inc. (HPTO), closed Thursday's trading session at $0.37, up 18.97%, on 500 volume with 2 trades. The average volume for the last 60 days is 6,352 and the stock's 52-week low/high is $0.025/$0.40.


Medovex Corporation (MDVX)

StockTwits reported on Medovex Corporation (MDVX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Medovex Corporation is the developer of the DenerveX® System. This is a new and novel device designed for enduring relief of Facet Joint Syndrome (FJS) related to chronic back pain, a non-addictive, non-opioid drug alternative capable of restoring a patient to a more normal and active lifestyle. The Company established to acquire and develop a diversified portfolio of potentially pioneering medical technology products. OTCQB-listed, Medovex is based in Atlanta, Georgia.

Facet Joint Syndrome (FJS) is also known as spinal osteoarthritis, spinal arthritis, or facet joint osteoarthritis. FJS is a significant health and economic problem in the U.S. and other countries in the EU and Rest of World affecting millions annually. Present treatment options are generally temporary. There is no proven long-lasting option for FJS.

The healthcare executives at Medovex have a proven record of accomplishment of building successful medical device and biotechnology companies. The Company’s DenerveX System is CE Marked in Europe. In addition, it is commercially available in Europe and certain other worldwide markets.

The DenerveX System is a highly differentiated technology. It denervates and removes capsular tissue from the Facet Joint in one single procedure. Treatment results from the combined effect of a deburring or polishing action and RF ablation treatment on the Facet Joint.

Employing this new technique, the slowly rotating burr removes the targeted facet joint synovial membrane and joint surface. This is while the heat ablation destroys tissue and denudes any residual nervous and synovial membrane overlying the joint, removing the end point sensory tissue of the joint.

In November, Medovex announced that it submitted an Investigational Device Exemption (IDE) with the U.S. Food and Drug Administration (FDA) for its DenerveX System targeting pain associated with the Facet Joint. The submission of the IDE marks a significant milestone for the Company.

This past September, Medovex announced that it launched its DenerveX System Device in Spain with leading distributor Prim SA. In October, Medovex announced that it launched its DenerveX System Device in Switzerland with distributor Spine Surgical. Switzerland is one of the most important locations for the worldwide medical technology industry.

Through combining first-class research facilities and highly-developed healthcare systems, Switzerland presents itself as a very attractive location for research, development and production for the medical technology sector.

The DenerveX System consists of the DenerveX Kit, which contains the DenerveX Device, a single use medical device and the DenerveX Pro-40 Power Generator. The DenerveX system is not yet FDA cleared.

Medovex Corporation (MDVX), closed Thursday's trading session at $0.42, up 5.00%, on 4,940 volume with 4 trades. The average volume for the last 60 days is 15,575 and the stock's 52-week low/high is $0.34/$1.35.


Ocean Thermal Energy Corporation (CPWR)

Tidal Energy Today, Insider Monkey, Stockhouse, OTC Markets, InvestorsHub, MarketWatch, YCharts, 4-Traders, Barchart, Investopedia, Marketbeat, and Simply Wall St reported on Ocean Thermal Energy Corporation (CPWR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Ocean Thermal Energy Corporation constructs and operates clean hydrothermal energy plants globally. The Company is a project developer for Ocean Thermal Energy Conversion (OTEC) plants that create renewable energy. It designs and develops deep-water hydrothermal clean-energy systems which produce fossil-fuel free electricity through OTEC and environmentally friendly cooling through Seawater Air Conditioning (SWAC).

Formed in 1998, Ocean Thermal Energy has its head office in Lancaster, Pennsylvania. The Company has additional offices in the Bahamas, the Cayman Islands, and the U.S. Virgin Islands.

Seawater Air Conditioning (SWAC) technology generates air conditioning without the use of chemical agents. Acting alone, SWAC can reduce electricity usage by up to 90 percent in comparison to traditional air conditioning systems. When developed in association with OTEC plants, SWAC operates completely without the use of fossil fuels.

OTEC leverages the temperature difference in the ocean between cold deep water and warm surface water in the tropics and subtropics to produce unlimited energy without the use of fossil fuels. In a closed cycle OTEC system, water flows through a large pipe and heat exchanger that heats a liquid with a low boiling point, such as ammonia.

As the boiling ammonia produces steam, it turns a turbine generator to produce electricity. A second pipe extracts cool deep water from the ocean that condenses the steam back to liquid form. As the ammonia is recycled, the process repeats, creating unlimited clean energy, 24 hours a day, 365 days a yea (The Rankine Cycle). OTEC uses the solar energy from the ocean. No fossil fuels are used.

Ocean Thermal Energy announced this past January that it has made significant progress on the development of its first OTEC EcoVillage. The Company has progressed toward the development of a SWAC system for the U.S. Military. Concerning the OTEC EcoVillage, the U.S. Virgin Islands’ Public Service Commission granted Ocean Thermal Energy regulatory approval for an OTEC plant.

The OTEC EcoVillage project consists of, in part, of an OTEC plant that will provide all power and water to about 400 residences. Additionally, it comprises a hotel, and shopping center, and models of sustainable agriculture, food production, and other economic developments. OTEC EcoVillage will be the first development in the world offering a net-zero carbon footprint.

Recently, Ocean Thermal Energy reaffirmed its commitment to the United Nations Sustainable Development Goals. Reports about the number of people without regular access to potable water are disturbing. According to the World Health Organization (WHO), 844 million people around the world lack access to a basic safe water source. An additional 2 billion have access to only contaminated water.

In April, Ocean Thermal Energy Corporation announced that it joined the Global Sustainable Tourism Council (GSTC). The GSTC is an international membership organization, created to manage the worldwide baseline standards for sustainable travel and tourism via the adoption of universal sustainable tourism principles. The GSTC Criteria serve as the international baseline standards for sustainability in travel and tourism.


Ocean Thermal Energy Corporation (CPWR), closed Thursday's trading session at $0.209, up 4.50%, on 5,964 volume with 5 trades. The average volume for the last 60 days is 141,490 and the stock's 52-week low/high is $0.0801/$12.25.


Black Cactus Global, Inc. (BLGI)

Stockopedia, InvestorsHub, OTC Markets, Insider Financial, 4-Traders, Morningstar, Stockhouse, Simply Wall St, MarketNewsUpdates, TipRanks, InvestorsHangout, Dividend Investor, PennyStockHub, StreetInsider, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, and The Street reported on Black Cactus Global, Inc. (BLGI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Black Cactus Global, Inc. is a technology development company listed on the OTC Markets Group’s OTCQB. The Company centers on Blockchain, machine learning, cryptocurrency, as well as the Internet of Things (IoT). Its corporate mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. Black Cactus Global is headquartered in Las Vegas, Nevada.

Black Cactus Global’s strategic plan is to become the first fully integrated digital financial institution with Blockchain technology as its operating foundation. The Company is developing Blockchain applications for Fintech, Healthcare, Media and Supply Chain using smart contracts and machine learning.

Black Cactus’ services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems. Its services additionally include Crypto Currencies, Internet of Things (IoT), Smart Contracts, and Fintech & Medtech.

Last month, Black Cactus Global announced that it entered into a Memorandum of Understanding (MOU) with NSB Holdings ehf (NSB) of Iceland. The details of the MOU map out the plan for Black Cactus to become the majority stakeholder of a bank in Iceland to create the first completely digital bank. Black Cactus Global, in cooperation with NSB, will convert and quickly develop the world’s first full-service Digital Bank founded on Blockchain Technology.

In addition, in January, Black Cactus Global announced that it entered into an MOU with the majority shareholders in an Indian Technology firm to establish a subsidiary of the Company. With this MOU, Black Cactus will become the largest stakeholder of an international Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will concentrate on and advance the use of its inventive Blockchain based IP.

Today, Black Cactus Global announced that Dr. Ramesh Para was appointed to the Board of Directors.  Dr. Para holds a Ph.D. in Management Information Systems and also an MBA.  He is Director of Sysveda UK Limited, which is an information sciences consultancy where he has led projects in Systems Development, Technical Architecture, Data Engineering and Distributed Applications.

Black Cactus Global, Inc. (BLGI), closed Thursday's trading session at $0.149, up 2.05%, on 743,704 volume with 178 trades. The average volume for the last 60 days is 480,448 and the stock's 52-week low/high is $0.0322/$0.838.


Grizzly Discoveries, Inc. (GZDIF)

MissionIR, InvestorsHub, Stockhouse, MarketWatch, 4-Traders, Investing News, Morningstar, Junior Mining Network, MineSnooper, Mining, Marketwired, YCharts, TradingView, Investor Ideas, Stockstream, and The Prospector News reported on Grizzly Discoveries, Inc. (GZDIF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

A diversified mineral exploration enterprise, Grizzly Discoveries, Inc. concentrates on developing its precious metals properties in southeastern British Columbia, and significant Potash and Diamond assets in Alberta. It mainly explores for gold, silver, copper, lead, zinc, potash, and diamond deposits. Incorporated in 2002, the Company has its head office in Edmonton, Alberta. Grizzly Discoveries lists on the OTC Markets.

The Company was previously known as Grizzly Diamonds Ltd. It changed its corporate name to Grizzly Discoveries Inc. in January of 2010.

The Company holds or has an interest in greater than 180,000 acres of precious-base metal and cobalt properties in British Columbia; and metallic and industrial mineral permits for potash totaling greater than 60,000 acres along the Alberta-Saskatchewan border. It also has an interest in over 161,000 acres of properties that host diamondiferous kimberlites in the Buffalo Head Hills area of Alberta.

In late March of this year, Grizzly Discoveries announced that it entered into a Letter of Intent (LOI) with a private group to purchase the Cobalt-Copper-Silver "Robocop Property", situated within the Fort Steele Mining District in south-eastern British Columbia.

The Robocop Property is about 45 kilometers (km) south of Fernie and 70 km southeast of Cranbrook. The Property is immediately north of the Canada-USA border.

The Property consists of 5 mineral claims totalling 9,891 acres. The Robocop Property is positioned east of Grizzly Discoveries’ Greenwood Property in south-eastern British Columbia.

Last week, Grizzly Discoveries announced that Kinross Gold Corporation's wholly-owned subsidiary, KG Exploration (Canada), Inc. (Kinross), provided Grizzly Discoveries with the proposed 2018 work program on the Grizzly Greenwood property. Kinross is planning a 1,200 meter (m) drill program at the Midway target this summer.

The program is a continuation of the 2017 proof-of-concept drilling that intersected silicification, alteration, anomalous geochemistry and minor quartz veining in 2 out of 3 holes along strike, warranting follow-up exploration.

The portion of Grizzly Discoveries’ 100 percent owned Greenwood Project being explored by Kinross comprises 131 claims. These form a contiguous package totaling around 27,346 hectares, representing roughly one third of Grizzly's land holdings at Greenwood.

Grizzly Discoveries, Inc. (GZDIF), closed Thursday's trading session at $0.068, even for the day. The average volume for the last 60 days is 15,208 and the stock's 52-week low/high is $0.0261/$0.114.


Metalla Royalty & Streaming Ltd. (MTAFF)

Proactive Investors, Junior Mining Network, MiningFeeds, InsiderFinancial, OTC Markets, Stockwatch, and Dividend Investor reported on Metalla Royalty & Streaming Ltd. (MTAFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Metalla Royalty & Streaming Ltd. formed to provide shareholders with leveraged precious metal exposure by acquiring royalties and streams. The Company has a strong pipeline of transactions with favorable rates of return. Metalla is working to accumulate a varied portfolio of royalties and streams with attractive returns. The Company previously went by the name Excalibur Resources Ltd. It changed its name to Metalla Royalty & Streaming Ltd. in December of 2016. Metalla Royalty & Streaming has its corporate office in Vancouver, British Columbia.

The Company’s Streams and Royalties include the Endeavor Silver Stream and the NLGM Silver Stream. In addition, they include the Joaquin Royalty; the Zaruma Royalty; the Hoyle Pond Extension Royalty; the West Timmins Extension Royalty; and the DeSantis Mine Royalty, as well as a variety of other royalties.

Last week, Metalla Royalty & Streaming and ValGold Resources Ltd. announced that they entered into a definitive arrangement agreement. Metalla will acquire all of the issued and outstanding common shares of ValGold Resources.

With this Arrangement Agreement, all of ValGold Resources’ issued and outstanding common shares will be exchanged for Metalla Royalty & Streaming common shares on the basis of 0.1667 of a Metalla common share for each ValGold common share.

ValGold Resources holds a 2 percent Net Smelter Return (NSR) royalty on certain claims of the Garrison Project that covers the Garrcon and Jonpol properties, and the eastern portion of the 903 Zone. The Garrison Project is situated roughly 100 kilometers east of Timmins, Ontario, and 40 kilometers north of Kirkland Lake.

This week, Metalla Royalty & Streaming announced that it acquired a 2 percent Net Smelter Return (NSR) royalty on the Akasaba West Property from Alexandria Minerals Corporation pursuant to a royalty purchase and sale agreement dated May 11, 2018. Pursuant to the Agreement, Metalla and Alexandria Minerals entered into an assignment and assumption agreement. The Royalty was transferred from Alexandria Minerals to Metalla.

The Akasaba West Property is a gold-copper deposit positioned in the Bourlamaque and Louvicourt Townships, Val d’Or, Quebec. The Akasaba West Property is owned and operated by Agnico Eagle Mines Limited.

Agnico acquired the project from Alexandria Minerals in 2014. Agnico has continued previous permitting and development activities, with a view to starting mining activities in 2020. The Royalty has been acquired for a total purchase price of $250,000 in cash.

Metalla Royalty & Streaming Ltd. (MTAFF), closed Thursday's trading session at $0.625, down 1.64%, on 32,542 volume with 22 trades. The average volume for the last 60 days is 58,266 and the stock's 52-week low/high is $0.3436/$0.7103.


The QualityStocks Company Corner

BLOCKStrain Technology Corp. (TSX-V: SR.H)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (SR.H).

BLOCKStrain Technology Corp. (TSX.V: SR.H), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

BLOCKStrain Technology Corp. (TSX.V: SR.H), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.


BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.


BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.


BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (SR.H), closed the day's trading session at $0.60, even for the day. The stock's 52-week low/high is $0.10/$0.30.

Recent News


Pivot Pharmaceuticals Inc. (PVOTF)

The QualityStocks Daily Newsletter would like to spotlight Pivot Pharmaceuticals Inc. (PVOTF).

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that its wholly-owned California subsidiary, Pivot Naturals, LLC has signed a Definitive Manufacturing and Supply Agreement ("the Agreement") with Stoney LLC ("Stoney"), a leading brand of cannabis products in the state of California. Also today, CannabisNewsWire released a report on the company detailing how PVOTF continues to strengthen its position in the cannabis industry through the development of its patent-protected bio-cannabis products.

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.

Research into the bioavailability of cannabinoid-based therapeutics shows that rates of absorption vary greatly between smoking cannabis to an orally-consumed product, with a difference noted even between individuals. Cannabinoids are degraded in the stomach and smoking may not appeal to patients for health or lifestyle reasons. Topical delivery, while a better alternative, has suffered from weak formulation issues. Transdermal cannabinoid delivery, on the other hand, could provide a better alternative route since it reduces side effects and bypasses other absorption issues. In addition, transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects.

Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in FDA and EMA approved human clinical trials, which have shown the delivery system enhances the bioavailability of many drugs and improves clinical outcomes. Pivot Green Stream is tasked with developing several natural health products containing cannabinoids (CBD) that can receive a Health Canada Natural Health Product (NHP) designation. This marketing method ensures a shorter development cycle and faster revenue generation opportunities.

Pivot Pharmaceuticals Inc., which has positioned itself as a growing and crucial vertical in the cannabis industry, represents a compelling opportunity in the biotechnology field. The company’s plans include working with Licensed Producers (LP) and Licensed Dealers (LD) to bring newer therapies to patients. The company has also applied to list on the Canadian Stock Exchange (CSE).

The global medical marijuana market is expected to reach a value of $55.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing number of states and countries gaining approval for using cannabis in therapeutic applications is expected to continue driving the market forward.

Pivot Pharmaceuticals has assembled a highly experienced management team, bringing together a wealth of clinical, commercial, product development and financial experience. Among the many healthcare targets in Pivot’s pipeline are cancer supportive care, pain and inflammation, women’s sexual dysfunction, dermatology and eye disease.

Pivot Pharmaceuticals Inc. (PVOTF), closed the day's trading session at $0.29, up 37.44%, on 264,652 volume with 128 trades. The average volume for the last 60 days is 91,382 and the stock's 52-week low/high is $0.047/$2.46.

Recent News


Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR)

The QualityStocks Daily Newsletter would like to spotlight Hammer Fiber Optic Holdings Corp. (HMMR).

Hammer Fiber Optic Holdings Corp d/b/a Hammer Communications (OTCQB:HMMR) and 1stPoint Communications announced today the launch of their Mobile Network Services Provider program.

Hammer Fiber Optic Holdings Corp. (HMMR), with headquarters in New Jersey, is a telecommunications company investing in the future of wireless technology. The company’s holdings include Hammer Fiber Optic Investments, Ltd., D/B/A Hammer Fiber, an Internet Service Provider (ISP) that offers internet, voice, video and data services in New Jersey as well as carrier services in Philadelphia and New York. Hammer Fiber serves residential and small business markets with high-capacity broadband, voice and video through direct fiber as well as its wireless fiber platform – Hammer Wireless® AIR technology.

Hammer Fiber recently completed the initial development phase of its advanced LTE fixed wireless system, which was designed and built upon its successfully deployed wireless technology suite. The expansion allows Hammer Fiber to add ultra-high capacity cellular broadband applications to its product portfolio including wholesale services such as backhaul support for cellular network operators. Designed to complement Hammer Fiber’s core business of home residential service, the company expects this latest innovation to help position Hammer Fiber as a leader in future 5G technology. The company intends to leverage the Fixed LTE system in conjunction with its already deployed Fixed Wireless DOCSIS 3.1 system to deliver on one of its core promises, to deliver high capacity broadband to markets across the country at dramatically lower cost than traditional wireline methods, including fiber. Live field testing of the new system begins in early 2018 in the U.S. with service availability to follow later in the year.

Hammer Fiber has also expanded its IaaS (Infrastructure-as-a-Service) cloud services to include support for the cryptocurrency and blockchain industry. Interested companies will be able to host their products over Hammer Fiber’s robust and modern server infrastructure, fiber network architecture and data center presence in some of the most secure locations in the New York, New Jersey and Philadelphia regions. Hammer Fiber’s servers feature best-in-class computing power, designed to allow enterprise businesses to reap the benefits of utilizing a cloud-based system without the massive cost of establishing or maintaining a corporate data center.

“Distributed architecture infrastructure, such as those utilized by blockchain entities mining cryptocurrencies or other new vertical markets utilizing blockchain technology, are growing exponentially and we are poised to fulfill a critical but fundamental need of this explosive new industry,” said Mark Stogdill, CEO of Hammer Fiber. “The distributed ledger architectures that blockchains are built on require secure and robust data processing networks, highly scalable power generation and a reliable fiber optic backbone infrastructure linking up data centers worldwide for them to exist, and that is what we at Hammer Fiber do really well.”

Hammer Fiber seeks to achieve its vision by employing an extremely qualified group of business professionals with diverse backgrounds and successful track records from a variety of related industries. HMMR’s seasoned leadership team combines startup expertise with a consummate understanding of the regional competitive telecommunications landscape in sales, marketing, engineering, construction and business development.

Hammer Fiber Optic Holdings Corp. (HMMR), closed the day's trading session at $1.44, up 10.77%, on 3,807 volume with 14 trades. The average volume for the last 60 days is 5,629 and the stock's 52-week low/high is $1.22/$48.00.

Recent News


Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC:REFG), a Nevada corporation specializing in state-of-the-art financial services structured to serve the medical cannabis and banking industries, announced today that it has acquired SpeedyGrow, a Wyoming corporation with licenses to grow and process hemp in the state of Colorado. 

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.04, up 9.89%, on 706,748 volume with 70 trades. The average volume for the last 60 days is 324,740 and the stock's 52-week low/high is $0.0161/$0.115.

Recent News


Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced the completion of the setup of 10,000 sq. ft. of greenhouse space in its Washington-based joint venture (“JV”) with Bougainville Ventures, Inc. To view the full press release, visit:

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.032, up 7.74%, on 7,141,048 volume with 310 trades. The average volume for the last 60 days is 5,234,581 and the stock's 52-week low/high is $0.0181/$0.0782.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for business, today announces the audio version of the press release titled “Earth Science Tech, Inc. (OTC:ETST) Completes Audit and Submits Form 10 to Become Fully Reporting.” To hear the Earth Science Tech AudioPressRelease (APR) version, visit: To read the original press release, visit:

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.7499, up 2.03%, on 45,160 volume with 10 trades. The average volume for the last 60 days is 15,976 and the stock's 52-week low/high is $0.324/$1.62.

Recent News


Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Adult recreational use depends on the enactment of Bill C-45 (the Cannabis Act) by the Canadian House of Commons, which is expected before the end of summer. Together, these two markets comprise a colossal adult consumer base of around 60 million, divided equally at about 30 million each. It’s a base that Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) is targeting.

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $6.18, off by 0.23%, on 25,220 volume with 106 trades. The average volume for the last 60 days is 36,395 and the stock's 52-week low/high is $6.035/$16.00.

Recent News


Uneeqo Inc. (OTC: UNEQ)

The QualityStocks Daily Newsletter would like to spotlight Uneeqo Inc. (UNEQ).

Uneeqo Inc. (OTC:UNEQ), an early stage technology company that recently incorporated and registered a new subsidiary, Serpentcoin Limited (“SCL”), in the United Kingdom, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

Uneeqo Inc. (OTC: UNEQ) is a Nevada corporation that recently incorporated and registered a new subsidiary, Serpentcoin Limited (“SCL”), in the United Kingdom. Through this subsidiary, Uneeqo has a new focus – a peer-to-peer digital token called “SerpentCoin” built upon a distributed, decentralized public ledger that is viewable and easily audited by transacting parties through unbreakable, encrypted smart contracts.

SerpentCoin is built upon Cardano, a technologically superior blockchain platform developed from a scientific philosophy by a global team of leading academics and engineers. SerpentCoin’s design platform includes several mission critical elements that directly support this forward-thinking technology that is constantly evolving in a fast-moving space.

Projects under development include:

  • Medusa – Each cryptocurrency requires a “wallet,” which is essentially a software application that can be installed on any computer or smartphone, to store tokens. SerpentCoin’s highly-engineered Medusa wallet will contain refined security features developed specifically for Cardano blockchain technology and protects assets with the most advanced cryptography. Medusa will not only support SerpentCoin tokens, but many others as well.
  • Temple – Think of this as a “treasury” which underpins the long-term core value of SerpentCoin. On every transaction through the SerpentCoin platform, 1.5 percent will be deposited in the platform’s Temple. Each quarter, Guardians (or holders of SerpentCoin) will have the chance to vote on how these treasury funds are invested into identified healthcare projects and technologies that benefit humanity.
  • Entwine – This refers to unbreakable smart contracts that allow SerpentCoin Guardians to make agreements on virtually anything while being assured the other party will meet its obligation. Through the use of double-deposit, theft is impossible, no escrow is needed, and no “middlemen” or websites are involved that could hold onto funds.

At the helm of the Uneeqo and SerpentCoin Limited team is Dr. Abel N J Haque, a business development professional with extensive experience in international business in the medical, technology and automotive sectors, as well as a leading consultant in regenerative medicine and cell therapy. Dr. Haque currently serves as an orthopaedic surgery technical consultant for Synergy Medical Technologies where he provides autologous stem cell cartilage transplants under contract to the Royal National Orthopaedic Hospital, University College, Long. In the past, Dr. Haque has held various positions at Wright Medical Europe and Stryker Corporation, along with many of its mergers and acquisitions.

Uneeqo Inc. (UNEQ), closed the day's trading session at $0.105, even for the day. The average volume for the last 60 days is 42,360 and the stock's 52-week low/high is $0.0075/$0.11.

Recent News


Hiku Brands Co. Ltd. (DJACF)

The QualityStocks Daily Newsletter would like to spotlight Hiku Brands Co. Ltd. (DJACF).

Hiku Brands Company Ltd. (CSE: HIKU) ("Hiku" or the "Company") is pleased to announce it has entered into a binding letter of intent ("LOI") with Oceanic Releaf Inc. ("Oceanic"), a Newfoundland & Labrador-based late-stage applicant under the Access to Cannabis for Medical Purposes Regulations ("ACMPR").

Headquartered in British Columbia’s picturesque Okanagan Valley, Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) iis a premium cannabis lifestyle brand growing high-quality handcrafted cannabis flower. Hiku’s wholly owned subsidiary is a licensed producer of cannabis under the ACMPR that has requested its Pre-Sales License Inspection, the last step prior to receiving a license to sell cannabis under the ACMPR. Hiku’s Dominion Facility is a state-of-the-art ACMPR licensed production facility capable of producing approximately 660 kg year of dried cannabis flower. Hiku’s second facility, a 22,580 sq ft warehouse, “the FUTURE LAB”, is targeting its Phase 1 completion by Q2 2018 and once the facility is fully built-out utilizing an industry leading multi-tier system powered by LED lighting provided by Fluence BioEngineering, Hiku’s annual production capacity is expected to be in excess of 5,000 kgs. Hiku was founded by the proven entrepreneurial team that started SAXX Underwear®.

On December 21, 2017, Hiku and TS Brandco Holdings Inc. (“Tokyo Smoke”) announced that they have entered into a binding Letter of Intent (“LOI”) to merger the two companies and create a uniquely positioned cannabis company combining a best-in-class craft cannabis producer with an award-winning lifestyle brand and retail-focused cannabis company. It is anticipated that the combined company resulting from the merger will use the name “Hiku Brands Company Ltd.” (“Hiku”) to refer to the brand house containing premium cannabis brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku recently closed on a $10 million strategic equity investment from Aphria Inc. (“Aphria”) (TSX:APH and US OTC: APHQF) to expand their product offering ahead of the recreational market.

Upon completion of the merger, Hiku will have a robust cash position of approximately $31 million, which it plans to invest in expanding its cannabis production capacity, growing its retail footprint, and adding select brands to its portfolio through highly strategic and complementary acquisitions.

About Tokyo Smoke
Founded in 2015 by Alan and Lorne Gertner, Tokyo Smoke is an award-winning cannabis lifestyle brand that brings sophistication and design to the fast-growing industry. With immersive experiences and design-first, non-dispensary retail spaces selling coffee, cannabis accessories and design products, the brand has six locations in Canada, with plans to expand nationwide. Recently named “Brand of the Year” at the Canadian Cannabis Awards, Tokyo Smoke has showcased excellence in brand storytelling, and has developed an international reputation as the go-to destination for engaging content offerings within the industry. With the acquisition of fellow designer cannabis brand Van der Pop, and by partnering with Aphria Inc. (TSX: APH and US OTC: APHQF) and WeedMD (TSXV: WMD), Tokyo Smoke continues to be the leading Canadian brand in the cannabis space.

About Hiku
Hiku is focused on handcrafted cannabis production, immersive retail experiences, and building a portfolio of iconic, engaging cannabis lifestyle brands. Hiku is differentiated as the only Canadian craft cannabis producer with a significant national retail footprint and a growing brand house including premium cannabis lifestyle brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku’s wholly owned subsidiary, DOJA Cannabis Ltd., is a federally licensed producer pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. The company operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Hiku Brands Co. Ltd. (DJACF), closed the day's trading session at $1.10036, up 0.03%, on 279,899 volume with 392 trades. The average volume for the last 60 days is 123,114 and the stock's 52-week low/high is $0.20/$3.8799.

Recent News


Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) (TASE:FRSX), a technological innovator in automotive vision systems and driver assistance technology, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.98, off by 3.87%, on 46,956 volume with 226 trades. The average volume for the last 60 days is 23,670 and the stock's 52-week low/high is $2.44/$11.70.

Recent News


Maxtech Ventures Inc. (CSE: MVT) (OTC: MTEHF) (FRANKFURT: M1N)

The QualityStocks Daily Newsletter would like to spotlight Maxtech Ventures Inc. (MTEHF).

Maxtech Ventures Inc. (CSE:MVT) (OTC:MTEHF) (FRANKFURT:M1N), a junior exploration company assembling and acquiring mineral assets worldwide with a view to becoming a pure-play, low-cost supplier of manganese to the agricultural, industrial and green technology markets, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

Maxtech Ventures Inc. (CSE: MVT) (OTC: MTEHF) (FRA: M1N), headquartered in Canada, is a junior exploration company assembling and acquiring mineral assets worldwide with a view to becoming a pure-play, low-cost supplier of manganese to the agricultural, industrial and green technology markets. Maxtech has assembled several high-grade manganese assets that it intends to develop with its established partners on the ground in strategic global regions.

Manganese is a diverse battery metal increasingly in high demand as an irreplaceable mainstay of steel production, an essential element of fertilizer in the agricultural sector, and as a vital resource in renewable battery technology. Maxtech Ventures is positioning itself to become a force in the green energy revolution where manganese is a critical element used in rechargeable batteries that power cars, hybrid vehicles, power tools and home appliances. LMD batteries, which typically use a 61 percent manganese in its mix and 4 percent lithium, are currently used in the Chevrolet Volt, Nissan Leaf, Hyundai Sonata and some Tesla-produced products. LMD batteries have numerous benefits including higher power output, thermal stability and improved safety compared to regular lithium-ion batteries.

“The price and demand for high-grade manganese is again on an upward trend. There are only a handful of junior pure play manganese explorers. This is an advantage Maxtech is looking to capitalize on as it expands its claims and strategic relationships in more mining jurisdictions,” said Maxtech Ventures CEO Peter Wilson.

Maxtech Ventures holds strategic partnerships; one of which is Grupo Maringa Ferro-Liga SA. Maringa is the second largest producer of high-grade manganese in South America with over 2,000 employees and over US$200 million in 2016 revenues.

Maxtech Ventures is currently advancing work on several high-grade manganese projects in Brazil with its first large land package in Juína in the State of Mato Grosso. This 40,000-plus hectare land package has assayed high-grade manganese results of 51.4 percent to 55.9 percent Mn. Detailed prospecting and geological studies are being continued on the Juína claims and a trial mining license (‘Guia de Utilização’) (GU) has been filed with the Departamento Nacional de Produção Mineral (DNPM) on one of the claims and the company is awaiting approval.

The company plans to expand its Brazilian operation into other states of the country including Pará and Goiás. Maxtech has signed a joint venture in the state of Pará on the exploration of 40,000 hectares as well as one in Goiás focused on the joint exploration, evaluation, and potential acquisition of manganese mineral deposits.

Maxtech is also currently preparing applications for licenses to explore potential high-grade manganese deposits in Zambia. The company will work closely with partner GeoQuest in its mandate to identify, joint-venture and acquire assets with high-grade manganese mineralization. GeoQuest is led and managed by Julian D.Green BSc., MSc., D.I.C., CGeol., EURGeol, FGS, FSAIMM. Julian has worked as a Professional Exploration Geologist in Eastern Europe, Australia and particularly Central and Southern Africa for a variety of mining and exploration companies including Tesla, KGHM, Rio Tinto and Caledonia.

Maxtech’s long-term strategy is to build an international industrial minerals company to produce and sell manganese ore and processed manganese into the global markets of Europe, North America and Asia. Maxtech Ventures has assembled a group of veterans in mining and exploration, acquisitions and field management to guide the development of its mineral interests.

CEO Peter Wilson has been the lead financier for public and private companies, raising over $300 million in equity and bond financings in the mineral and energy fields over the past two decades. As an experienced corporate executive, Wilson has extensive relationships in project acquisition, corporate structure and finance specializing in, but not limited to, the global resource sector.

John Harper, consulting geologist, is an international mineral exploration geoscientist and consultant with over 30 years of industry experience in base and precious metals, manganese, uranium and diamond exploration. He is a member in good standing of the Association of Professional Engineers and Geoscientists of Alberta (APEGA) and Ontario (APGO). His international experience has taken him to projects in Africa and Brazil where he managed comprehensive programs for Cancana’s manganese claims.

Maxtech Ventures Inc. (MTEHF), closed the day's trading session at $0.26, off by 8.48%, on 51,506 volume with 30 trades. The average volume for the last 60 days is 49,519 and the stock's 52-week low/high is $0.1338/$0.482.

Recent News



The QualityStocks Daily Newsletter would like to spotlight FANDOM SPORTS Media Corp. (FDMSF).

FANDOM SPORTS Media Corp. (CSE:FDM) (OTC:FDMSF) (FRANKFURT:TQ42) (“FANDOM SPORTS” or the “Company”) announces that they have retained the services of an industry leading mobile app marketing and strategy firm. Also today, NetworkNewsWire released a report on the company detailing FDMSF’s applauding the U.S. Supreme Court’s landmark decision that overturns a 1992 federal ban on sports betting, opening the door for states to pass laws legalizing sports gambling.

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) taps into the primal, unfiltered passion of sports fans from around the world by providing an uncensored social media platform delivered through the FANDOM SPORTS mobile app. As an aggregator, curator and instigator of both company-created and user-generated content, the FANDOM SPORTS app is designed to entertain sports enthusiasts with real-time, interactive content on a mobile only app that offers bragging rights and real-life rewards. True sports addicts will appreciate an app that allows fans to pick a fight or create their own FanFights and rule over others as they trash talk their way to victory. The FANDOM SPORTS proprietary data centric “argument engine” measures and scores opinionated dialogue, as well as establishes consensus, giving fans and users the ability to dive deeper into one-of-a-kind cultural moments, cheer on favorite sports teams and slam dunk some sweet rewards.

Building on the company’s tag line – “Pick a Fight” – the FANDOM SPORTS app provides an always fresh, authentic rush of deeper-than-surface interactive content that resonates with the targeted age demographic of 18-34. Intense sports fans aren’t afraid of stepping up to the plate to engage other users by unleashing their opinions within the app’s structured debate resolution tool coined “FanFights.” Sports-loving fans can explore, gloat, vote, invite friends, create provocative FanFight topics and play to win while inside the FANDOM SPORTS app, which is currently available in the Apple App store and coming to the Google Play store imminently. The company’s self-learning algorithm predicts and collects user preferences while building relevant personalized FanFight channels, bringing the concept of competitive, in-your-face conversation to a whole new level of sports entertainment.

The FANDOM SPORTS app is free to play (F2P) with in-app purchase and subscription capabilities. The gaming aspect of the ecosystem is built on behavioral economics and delivers multiple revenue streams by maximizing average revenue per daily active user (ARPDAU) and user-generated content (UGC), with select placement of high-impact video and moment-based marketing as part of the brand-sponsored FanFights and in-app offers. The global platform enables applications (either FANDOM SPORTS created or 3rd party apps) to be operated in partnership with leading sports themed brands, leagues, and service providing companies within three verticals – live action, eSports, & fantasy – from around the world by supplying “interactive sports entertainment” to fans. The FANDOM SPORTS platform creates a bullet-proof snapshot of the app’s fan base through a Blockchain supported “PlayerCard” in tandem with the “Engagement Score”, which doubles as an invaluable acquisition and retention tool for its business operators. FANDOM SPORTS hosted transactions are placed on the distributed ledger, making them immutable and public to verified users interacting within the business ecosystem. Tracking this digital footprint provides extremely valuable metadata generated by users’ very dynamic behavior and sports passion.

FANDOM SPORTS’ Brand and Sponsorship partners are harnessing the affluent sports fans age 18-34 with integrated marketing content and service experience. The moments-based marketing integration will translate through FanCoin redemption, in exchange for items provided by programs established by FANDOM SPORTS and its clients. These programs are a key part of the business model and covers, as an example, the following partners; Sports Leagues, TelCo’s service offerings, and Content owners (i.e. FANDOM SPORTS provides new paying customers to the owners of pay-per-view platforms).

“Pick A Fight. Talk Trash. Get Rewarded.”

FANDOM SPORTS Media is an entertainment company that aggregates, curates and produces unique fan-focused content.

The FANDOM SPORTS App is the Company’s core product, which is the ultimate destination for unfiltered raw sports talk. The app allows passionate sports fans to unleash their primal sports passions, pick fights and earn rewards.

So download the app and bring your crew. Talking trash is better with friends. The more you invite, the more FanCoins you earn.

You may also visit the Company’s website at or contact them directly at


The CSE has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. This news release may contain forward-looking statements. These forward-looking statements do not guarantee future events or performance and should not be relied upon. Actual outcomes may differ materially due to any number of factors and uncertainties, many of which are beyond the Company’s control. Some of these risks and uncertainties may be described in the Company’s corporate filings (posted at

The Company has no intention or obligation to update or revise any forward-looking statements due to new information or events

FANDOM SPORTS Media Corp. (FDMSF), closed the day's trading session at $0.1056, off by 14.15%, on 14,500 volume with 4 trades. The average volume for the last 60 days is 12,401 and the stock's 52-week low/high is $0.0629/$0.3911.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.